{
    "eid": "2-s2.0-85081646277",
    "title": "Perspectives in allergen-specific immunotherapy: Molecular evolution of peptide-and protein-based strategies",
    "cover-date": "2020-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Biochemistry",
            "@code": "1303",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Molecular Biology",
            "@code": "1312",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Cell Biology",
            "@code": "1307",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "Allergic disease",
        "Blocking antibodies",
        "Hypoallergen",
        "IgE binding epitope",
        "Immunotherapy",
        "Recombi-nant",
        "Synthetic peptide",
        "T cell epitope"
    ],
    "authors": [
        "Alain Jacquet"
    ],
    "citedby-count": 6,
    "ref-count": 169,
    "ref-list": [
        "Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study",
        "Immunotherapy with a standardized Dermato-phagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children",
        "Prevention of new sensitizations in asthmatic children monosensi-tized to house dust mite by specific immunotherapy. A six-year fol-low-up study",
        "Allergy immunotherapy adherence and delivery route: location does not matter",
        "Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity",
        "Efficacy of subcutaneous and sublingual immunother-apy with grass allergens for seasonal allergic rhinitis: A meta-analysis-based comparison",
        "Sublingual or subcutaneous immuno-therapy for allergic rhinitis?",
        "Guideline recommendations on the use of allergen immunotherapy in house dust mite allergy: Time for a change?",
        "International consensus on allergy immunotherapy",
        "Patterns of IgE sensitization in house dust mite-allergic patients: implications for allergen immunotherapy",
        "Allergen Extracts for In Vivo Diagnosis and Treatment of Allergy: Is There a Future?",
        "Innate immune responses in house dust mite allergy",
        "Emerging roles of the protease allergen Der p 1 in house dust mite-induced airway inflammation",
        "Molecular diagnosis and pre-cision medicine in allergy management",
        "Mechanisms of allergen immunother-apy for inhaled allergens and predictive biomarkers",
        "IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses",
        "IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen in-terception and Fc gamma RIIb cross-linking",
        "Facilitated antigen presentation and its inhibition by blocking IgG antibodies depends on IgE repertoire complexity",
        "Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immu-notherapy",
        "Passive immunization with allergen-specific antibodies",
        "Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement",
        "T Cell Epitope Peptide Therapy for Allergic Diseases",
        "Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice",
        "Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I",
        "Successful immunotherapy with T-cell epi-tope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom",
        "Treatment of cat allergy with T-cell reactive peptides",
        "Safety and Tolerabil-ity of Escalating Doses of House Dust Mite-Peptide Antigen De-sensitization (HDM-PAD)",
        "Four doses of Der p derived synthetic peptide im-muno-regulatory epitopes over 3 months results in a persistent treatment effect at 1 year on symptoms of House Dust Mite allergy",
        "A short course of synthetic peptide immuno-regulatory epitopes derived from grass allergens leads to a reduction in grass allergy symptoms",
        "Valida-tion of peptide immunotherapy as a new approach in the treatment of allergic rhinoconjunctivitis: the clinical benefits of treatment with Amb a 1-derived T cell epitopes",
        "Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy",
        "Fel d 1-derived peptide antigen desensiti-zation shows a persistent treatment effect 1 year after the start of dosing: a randomized, placebo-controlled study",
        "Novel birch pollen specific immunotherapy formulation based on contiguous overlapping peptides",
        "Safety and immunogenicity of immunotherapy with Bet v 1-derived contiguous overlapping peptides",
        "Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1-derived contiguous overlapping peptides in patients with allergic rhinocon-junctivitis: Results of a phase IIb study",
        "Lolium perenne peptides for treatment of grass pollen al-lergy: A randomized, double-blind, placebo-controlled clinical trial",
        "Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B-cell response in seasonal allergic rhinitis patients",
        "Short course of grass allergen peptides immunotherapy over 3 weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: A randomized, multicenter, double-blind, placebo-controlled trial",
        "Allergen-specific immunotherapy with recombinant grass pollen al-lergens",
        "Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinocon-junctivitis",
        "Development and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen-allergic patients",
        "Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, pla-cebo-controlled, double-blind, double-dummy study",
        "Bet v 1, the major birch pollen allergen, and Mal d 1, the major apple al-lergen, cross-react at the level of allergen-specific T helper cells",
        "Efficacy and safety of 4 months of sublingual immuno-therapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen-related apple allergy",
        "Low-Dose Allergen-Specific Immunotherapy Induces Tolerance in a Murine Model of Shrimp Allergy",
        "Intranasal, liposome-adjuvanted cockroach allergy vaccines made of refined major allergen and whole-body extract of Periplaneta americana",
        "Immunotherapy using algal-produced Ara h 1 core domain suppresses peanut allergy in mice",
        "Mouse Model of Cat Allergic Rhinitis and Intra-nasal Liposome-Adjuvanted Refined Fel d 1 Vaccine",
        "Immunotherapeutic efficacy of liposome-encapsulated refined allergen vaccines against Dermatophagoides pteronyssinus allergy",
        "Subcutaneous immunotherapy with purified Der p1 and 2 suppresses type 2 immunity in a murine asthma model",
        "Contributions and Future Directions for Structural Biology in the Study of Allergens",
        "Characterization of a hybrid protein de-signed with segments of allergens from Blomia tropicalis and Der-matophagoides pteronyssinus",
        "Hypoallergenic Der p 1/Der p 2 combination vaccines for immunotherapy of house dust mite allergy",
        "Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen-specific immunotherapy",
        "T Cell Epi-tope-Containing Domains of Ragweed Amb a 1 and Mugwort Art v 6 Modulate Immunologic Responses in Humans and Mice",
        "Generation of a chimeric dust mite hypoallergen using DNA shuffling for application in allergen-specific immunotherapy",
        "Reduction of the in vivo allergenicity of Der p 2, the major house-dust mite al-lergen, by genetic engineering",
        "A hypoallergenic variant of Der p 1 as a candidate for mite allergy vac-cines",
        "Heat denaturation affects the ProDer p 1 IgE reactivity and downregulates the development of the specific allergic response",
        "Protein unfolding strongly modulates the allergenicity and immunogenicity of Pru p 3, the major peach allergen",
        "A modified, hypoallergenic variant of the Ricinus communis Ric c1 protein retains biological activity",
        "Hypoallergenic Variant of the Major Egg White Allergen Gal d 1 Produced by Disruption of Cysteine Bridges",
        "The allergen Mus m 1.0102: Dissecting the relationship between molecular conformation and allergenic potency",
        "Epitope Mapping of Rhi o 1 and Generation of a Hypoallergenic Variant: A CANDIDATE MOLECULE FOR FUNGAL ALLERGY VACCINES",
        "Immunization with Hypoallergens of shrimp allergen tropomyosin inhibits shrimp tropomyosin specific IgE reactivity",
        "Phl p 1-specific human mono-clonal IgE and design of a hypoallergenic group 1 grass pollen allergen fragment",
        "Hypoallergenic profilin--a new way to identify allergenic determinants",
        "Hypoallergenic mutants of the Timothy grass pollen allergen Phl p 5 generated by proline mutations",
        "Identification of critical amino acids in an immunodominant IgE epitope of Pen c 13, a major allergen from Penicillium citrinum",
        "Synthesis of hypoallergenic derivatives of the major allergen Fag t 1 from tartary buckwheat via sequence restructuring",
        "A non-allergenic Ole e 1-like protein from birch pollen as a tool to design hypoallergenic vaccine candidates",
        "A mutant of the major melon allergen, Cuc m 2, with reduced IgE binding capacity is a good candidate for specific im-munotherapy",
        "Antigenic Determinants of the Bilobal Cockroach Allergen Bla g 2",
        "Reduced allergenic potency of VR9-1, a mutant of the major shrimp allergen Pen a 1 (tropomyosin)",
        "High-resolution crystal structure and IgE recognition of the major grass pollen allergen Phl p 3",
        "Molecular evolution of hypoallergenic hybrid proteins for vaccination against grass pollen allergy",
        "Hypoallergenic derivatives of Fel d 1 obtained by rational reassembly for allergy vaccination and tolerance induction",
        "Vaccination with genetically engineered allergens prevents progression of allergic disease",
        "Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives",
        "Characterization of a hypoallergenic re-combinant Bet v 1 variant as a candidate for allergen-specific im-munotherapy",
        "Double-blind, placebo-controlled, dose-ranging study of new recombinant hypoallergenic Bet v 1 in an environmental exposure chamber",
        "Allergy immunotherapy with a hypoallergenic recombinant birch pollen allergen rBet v 1-FV in a randomized controlled trial",
        "BASALIT trial: double-blind placebo-controlled allergen immunotherapy with rBet v 1-FV in birch-related soya allergy",
        "Development of a hypoallergenic recombinant parvalbumin for first-in-man subcutaneous immunotherapy of fish allergy",
        "Blocking antibodies induced by immunization with a hypoallergenic parvalbumin mutant reduce allergic symptoms in a mouse model of fish allergy",
        "A phase 1 study of heat/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy",
        "Recombinant allergy vaccines based on allergen-derived B cell epitopes",
        "Non-anaphylactic surface-exposed peptides of the major birch pollen allergen, Bet v 1, for preventive vaccination",
        "Prophylactic and therapeutic vaccination with carrier-bound Bet v 1 peptides lacking allergen-specific T cell epitopes reduces Bet v 1-specific T cell responses via blocking antibodies in a murine model for birch pollen allergy",
        "A combination vaccine for allergy and rhinovirus infections based on rhinovirus-derived surface protein VP1 and a nonal-lergenic peptide of the major timothy grass pollen allergen Phl p 1",
        "Dissec-tion of the IgE and T-cell recognition of the major group 5 grass pollen allergen Phl p 5",
        "Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy",
        "A B Cell Epitope Peptide Derived from the Major Grass Pollen Allergen Phl p 1 Boosts Allergen-Specific Secondary Antibody Responses without Allergen-Specific T Cell Help",
        "Carrier-bound, nonallergenic Ole e 1 peptides for vaccination against olive pollen allergy",
        "Carrier-bound Alt a 1 peptides without allergenic activity for vaccination against Alternaria alternata allergy",
        "A hypoallergenic cat vaccine based on Fel d 1-derived peptides fused to hepatitis B PreS",
        "Carrier-bound nonallergenic Der p 2 peptides induce IgG antibodies blocking allergen-induced basophil activation in allergic patients",
        "Conversion of Der p 23, a new major house dust mite allergen, into a hypoallergenic vaccine",
        "Skin test evaluation of a novel peptide carrier-based vaccine, BM32, in grass pollen-allergic patients",
        "Comparison of the immunogenicity of BM32, a recombinant hypoallergenic B cell epitope-based grass pollen allergy vaccine with allergen extract-based vaccines",
        "Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy",
        "Safety and efficacy of immuno-therapy with the recombinant B-cell epitope-based grass pollen vaccine BM32",
        "De-sign, engineering and in vitro evaluation of MHC class-II targeting allergy vaccines",
        "Targeting the MHC class II pathway of antigen presentation enhances immunogenicity and safety of allergen immunotherapy",
        "Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections",
        "A chimeric human-cat fusion protein blocks cat-induced allergy",
        "A chimeric human-cat Fcgamma-Fel d1 fusion protein inhibits systemic, pulmonary, and cutaneous allergic reactivity to intratracheal challenge in mice sensitized to Fel d1, the major cat allergen",
        "Chimeric human fcgamma-allergen fusion proteins in the prevention of al-lergy",
        "Prevention and treatment of allergic inflammation by an Fc\u03b3-Der f2 fusion protein in a murine model of dust mite-induced asthma",
        "Blockade of peanut allergy with a novel Ara h 2-Fc\u03b3 fusion protein in mice",
        "New approaches to allergen immunotherapy",
        "Immune adjuvant effect of molecularly-defined toll-like receptor ligands",
        "Pollinex Quattro: an innovative four injections immunotherapy in allergic rhinitis",
        "Fusion protein of TLR5-ligand and allergen potentiates activation and IL-10 secretion in murine myeloid DC",
        "A fusion protein of flagellin and ovalbumin suppresses the TH2 response and prevents murine intestinal allergy",
        "Conjugation of wildtype and hypoallergenic mugwort allergen Art v 1 to flagellin induces IL-10-DC and suppresses allergen-specific TH2-responses in vivo",
        "Fusion proteins of flagellin and the major birch pollen allergen Bet v 1 show enhanced immunogenic-ity, reduced allergenicity, and intrinsic adjuvanticity",
        "Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes T(H)1 cytokine expression while downregulating T(H)2 cytokine expression in PBMCs from human patients with ragweed allergy",
        "Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis",
        "Toll-like receptor-2 agonist-allergen coupling efficiently redirects Th2 cell responses and inhibits allergic airway eosinophilia",
        "A Fusion Protein Consisting of the Vaccine Adjuvant Monophosphoryl Lipid A and the Allergen Ovalbumin Boosts Allergen-Specific Th1, Th2, and Th17 Responses In Vitro",
        "A novel allergen-adjuvant conjugate suitable for specific immu-notherapy of respiratory allergy",
        "Treatment with 8-OH-modified adenine (TLR7 ligand)-allergen conjugates decreases T helper type 2-oriented murine airway inflammation",
        "Efficacy and tolerability of a house dust mite allergoid in allergic bronchial asthma: a randomized dose-ranging trial",
        "Dose-response relationship of a new Timothy grass pollen aller-goid in comparison with a 6-grass pollen allergoid",
        "Preclinical safety and immunological efficacy of Alter-naria alternata polymerized extracts",
        "Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis",
        "EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis",
        "Novel vaccines targeting dendritic cells by coupling allergoids to nonoxidized mannan enhance allergen uptake and induce functional regulatory T cells through programmed death ligand 1",
        "The human microbiome, asthma, and allergy",
        "Microbiota and Type 2 immune responses",
        "Lung microbiota promotes tolerance to allergens in neonates via PD-L1",
        "Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differen-tiation",
        "Lactic acid bacteria differ in their ability to induce functional regulatory T cells in humans",
        "Immunotherapy of allergic diseases using probiotics or recombinant probiotics",
        "Immunomodulatory properties of Lacto-bacillus plantarum and its use as a recombinant vaccine against mite allergy",
        "Recombinant Lactobacillus plantarum inhibits house dust mite-specific T-cell responses",
        "Mucosal delivery of allergen peptides expressed by Lactococcus lactis inhibit allergic responses in a BALB/c mouse model",
        "Suppression of dust mite allergy by mucosal delivery of a hypoallergenic derivative in a mouse model",
        "Genetically engineered Lacto-coccus lactis protect against house dust mite allergy in a BALB/c mouse model",
        "Inhibition of allergen-induced airway inflammation and hyperreactivity by recombinant lactic-acid bacteria",
        "Constitutive delivery of bovine beta-lactoglobulin to the digestive tracts of gnotobiotic mice by engineered Lactobacillus casei",
        "Allergy therapy by intranasal administration with recombinant Lactococcus lactis Producing bovine beta-lactoglobulin",
        "Oral administration of recombinant Lactococcus lactis expressing bovine beta-lactoglobulin partially prevents mice from sensitization",
        "Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis se-creting ovalbumin",
        "Modulation of peanut-induced allergic immune responses by oral lactic acid bacte-ria-based vaccines in mice",
        "Sublingual Immunotherapy with Sal k1 Expressing Lactococcus lactis Down-regulates Th2 Immune Responses in Balb/c Mice",
        "Effects of orally applied Fes p1-displaying L. plantarum WCFS1 on Fes p1 induced allergy in mice",
        "Prophylactic effect of Lactobacillus oral vaccine expressing a Japanese cedar pollen allergen",
        "Neonatal colonization of mice with Lactobacillus plantarum producing the aeroaller-gen Bet v 1 biases towards Th1 and T-regulatory responses upon systemic sensitization",
        "Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1",
        "Current concepts in the prevention of atopic dermatitis",
        "Administration of a pro-biotic with peanut oral immunotherapy: A randomized trial",
        "Selective stimulation of murine cytotoxic T cell and antibody responses by particulate or monomeric hepatitis B virus surface (S) antigen",
        "Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns",
        "Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults",
        "Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy",
        "Allergens displayed on virus-like particles are highly immunogenic but fail to activate human mast cells",
        "Adeno-associated virus-like particles as new carriers for B-cell vaccines: testing immunogenic-ity and safety in BALB/c mice",
        "Prevention of allergy by virus-like nanoparticles (VNP) delivering shielded versions of major allergens in a humanized murine allergy model",
        "Induction of bystander tolerance and immune deviation after Fel d 1 peptide immunotherapy",
        "Novel Delivery Routes for Allergy Immu-notherapy: Intralymphatic, Epicutaneous, and Intradermal",
        "Windows of opportunity for tolerance induction for allergy by studying the evolution of allergic sensitization in birth cohorts",
        "Evolution and predictive value of IgE responses toward a comprehensive panel of house dust mite allergens during the first 2 decades of life",
        "Aeroallergen sensitization and allergic disease phenotypes in Asia",
        "Group 1 Allergen Genes in Two Species of House Dust Mites, Dermatophagoides farinae and D. pteronyssinus (Acari: Py-roglyphidae): Direct Sequencing, Characterization and Polymor-phism",
        "Genetic polymorphisms of major house dust mite allergens"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Chulalongkorn Academic Advancement",
        "S&T Postgraduate Education and Research Development Office",
        "PERDO"
    ]
}